Ventricular Thrombus
Conditions
Brief summary
To observe the effectiveness and safety of different therapies-non-vitamin K antagonist oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) or antiplatelet agents and non-antithrombotic therapy - for the treatment of VT.
Interventions
DRUGnon-vitamin K antagonist oral anticoagulants (NOACs)
Collecting information of patients with VT who received NOACs
Collecting information of patients with VT who received VKAs
Collecting information of patients with VT who received antiplatelet agents
Collecting information of patients with VT without any antithrombotic therapy
Sponsors
China National Center for Cardiovascular Diseases
Study design
Observational model
OTHER
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adults with ventricular thrombus(VT), regardless of sex, basic diseases, occupation or education; * The VT should be found newly within 3 months; * The observational phase should last until the time that patients who had achieved thrombus resolution. The following up period after the phase ended should continue for at least 3 months.
Exclusion criteria
* Individuals received standard antithrombotic therapy within 4 weeks; * Individuals received the thrombectomy therapy, ventricular aneurysm resection or heart transplantation within 6 weeks since the VT was found in the first time; * Had a long history of VT more than three months.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Thrombus resolution in 12 weeks follow-up | 12 weeks | Thrombus resolution in 12 weeks follow-up |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Thrombus resolution in 6 months follow-up | 6 months | Thrombus resolution in 6 months follow-up |
| Thrombus resolution in 12 months follow-up | 12 months | Thrombus resolution in 12 months follow-up |
| Thrombus resolution in 6 weeks follow-up | 6 weeks | Thrombus resolution in 6 weeks follow-up |
| Bleeding | 12 months | Bleeding |
| All-cause death | 12 months | All-cause death |
| Thromboembolism events | 12 months | Thromboembolism events |
Countries
China
Outcome results
None listed